EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation

Ying Chen, Xiaoteng Cui iD, Xinyi Shi, Xu Yang, Yujing Cao, Haolin Li, Qi Zhan, Qixue Wang, Ang Li, Qihong Cheng, Yunfei Wang, Junhu Zhou und 3 weitere

Advanced Science · 2026

DOI: 10.1002/advs.73843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Ying Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Center, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Cholesterol, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing-Tianjin-Hebei Region Basic Research Cooperation Special Project/Tianjin Science and Technology Program Project, Tianjin Key Project of Municipal Education Commission Scientific Research Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain metastasis is a major cause of mortality in advanced lung adenocarcinoma (LUAD). Accumulating evidence indicates that dysregulated lipid metabolism contributes to metastatic colonization; however, how cholesterol functions as a downstream effector within established lipid‐metabolic programs to regulate key steps of the LUAD brain metastasis (LUAD‐BM) cascade remains incompletely defined. Here, we demonstrate that cholesterol directly engages EGFR and stabilizes its membrane localization by blocking ubiquitin–proteasome–mediated degradation, thereby sustaining AKT/NF‐κB signaling. This signaling axis promotes glycolytic reprogramming and epithelial–mesenchymal transition in LUAD cells, enhancing metastatic capacity and resistance to TKIs. Cholesterol also disrupts blood–brain barrier integrity by reducing endothelial membrane fluidity and accelerating Claudin‐5 ubiquitination and degradation. Within the brain microenvironment, cholesterol directly interacts with IL‐4Rα, facilitating its recruitment into lipid rafts and activation of JAK1/STAT6 signaling, which drives microglial M2 polarization and establishes a permissive pre‐metastatic niche. The cholesterol‐lowering drug atorvastatin reverses these tumor‐intrinsic and microenvironmental effects and suppresses LUAD brain metastasis in vivo. Retrospective clinical analyses further show that hypercholesterolemia is associated with shortened survival in LUAD‐BM patients, whereas statin use correlates with improved outcomes. These findings identify cholesterol as a functional mediator downstream of lipid‐metabolic dysregulation and therapeutic target in LUAD‐BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCholesterolAdenocarcinoma of LungLung NeoplasmsEpithelial-Mesenchymal TransitionMetabolic ReprogrammingAnimalsErbB ReceptorsHumansMiceTumor MicroenvironmentCell Line, TumorSignal TransductionFemaleBlood-Brain Barrier

Stichwörter der Autor:innen

EGFRbrain metastasischolesterolglycolytic reprogramminglung adenocarcinoma

Substanzen

CholesterolErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Neuro-Oncology Center, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
  • Laboratory of Neuro-oncology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Neuro-Oncology Center, Huanhu Hospital Affiliated to Tianjin University, Tianjin, China.

ORCID-Profile: Xiaoteng Cui

Förderung

  • National Natural Science Foundation of China
  • Beijing-Tianjin-Hebei Region Basic Research Cooperation Special Project/Tianjin Science and Technology Program Project
  • Tianjin Key Project of Municipal Education Commission Scientific Research Plan

Zitieren

APA

Chen, Y., Cui, X., Shi, X., Yang, X., Cao, Y., Li, H., Zhan, Q., Wang, Q., Li, A., Cheng, Q., Wang, Y., Zhou, J., Wang, M., Kang, C., & Liu, X. (2026). Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation. Advanced Science. https://doi.org/10.1002/advs.73843

Vancouver

Chen Y, Cui X, Shi X, Yang X, Cao Y, Li H, et al. Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation. Advanced Science. 2026. doi:10.1002/advs.73843

BibTeX
@article{Chen2026,
  author = {Chen, Ying and Cui, Xiaoteng and Shi, Xinyi and Yang, Xu and Cao, Yujing and Li, Haolin and Zhan, Qi and Wang, Qixue and Li, Ang and Cheng, Qihong and Wang, Yunfei and Zhou, Junhu and Wang, MingJie and Kang, Chunsheng and Liu, Xiaomin},
  title = {Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.73843}
}
Kostenlos starten →